Epimedium brevicornu Maxim.-derived extracellular vesicle-like particles stimulate VEGF-mediated angiogenesis to alleviate postmenopausal osteoporosis
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Xiuping Cai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Key Laboratory of Chinese Medicine Research on Prevention and Treatment of Osteoporosis, The Third Affiliated Hospital of Guangzhou Univers…. Hauptthemen laut MEDLINE: Osteoporosis, Postmenopausal, Epimedium, Extracellular Vesicles, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Medical Research Foundation.
Abstract (Originalsprache)
BACKGROUND: Postmenopausal osteoporosis (PMOP), a bone disease causing fragility fractures, affects millions of postmenopausal women. Epimedium brevicornu Maxim.(EP) shows anti-osteoporotic potential, but its active components and mechanisms remain unclear. Epimedium brevicornu Maxim.-derived extracellular vesicle-like particles (EP-EVLPs) are naturally occurring bioactive constituents. To date, no studies have comprehensively addressed the dual regulatory role of EP-EVLPs in PMOP. PURPOSE: To investigate the bone-targeting capability and therapeutic efficacy of EP-EVLPs against PMOP. METHODS: EP-EVLPs were isolated from fresh EP leaves via differential ultracentrifugation and systematically characterized using transmission electron microscopy, nanoparticle tracking analysis, SDS-PAGE, agarose gel electrophoresis, thin-layer chromatography, and high-performance liquid chromatography. In vivo studies evaluated bone-targeting specificity, anti-osteoporotic activity, and biocompatibility in PMOP models. In vitro analyses included: 1) Osteogenic differentiation assessment of hBMSCs and MC3T3 cells through immunohistochemical staining and RT-qPCR; 2) HUVEC proliferation and apoptosis assays via CCK-8 and flow cytometry; 3) Angiogenic potential evaluation using bioinformatic analysis, wound healing, transwell migration, tube formation assays and ELISA. RESULTS: EP-EVLPs were isolated from Epimedium brevicornu Maxim. in the form of cup-shaped, bilayer nanoparticles, containing nucleic acids, proteins, lipids, epimedin C, and key anti-osteoporotic compounds (icariin). In vivo experiments revealed their preferential accumulation in osteoporotic femora, effectively mitigating bone loss without hepatorenal toxicity. Mechanistically, EP-EVLPs dose-dependently upregulated VEGF expression, enhancing HUVEC proliferation, migration, and tube formation. This angiogenesis-driven remodeling of the osseous vascular niche correlated with restored bone homeostasis. CONCLUSION: We identify EP-EVLPs rescue postmenopausal osteoporosis through icariin-mediated activation of VEGF-driven angiogenesis. This plant-derived nano-platform restores bone homeostasis by revascularization-coupled osteogenesis, establishing a targeted therapeutic strategy with translational promise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Key Laboratory of Chinese Medicine Research on Prevention and Treatment of Osteoporosis, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510378, China; Guangdong Engineerin…
- The Third Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510375, China.
- The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510375, China.
- Department of Hematology-Oncology, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510378, China. Electronic address: yang63466@126.com.
Förderung
- National Natural Science Foundation of China
- Guangdong Medical Research Foundation
Zitieren
APA
Cai, X., Qiu, T., Shen, J., Xu, Y., Wu, Z., Lin, J., Yang, H., Zhao, Q., & Zhao, K. (2025). Epimedium brevicornu Maxim.-derived extracellular vesicle-like particles stimulate VEGF-mediated angiogenesis to alleviate postmenopausal osteoporosis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157259
Vancouver
Cai X, Qiu T, Shen J, Xu Y, Wu Z, Lin J, et al. Epimedium brevicornu Maxim.-derived extracellular vesicle-like particles stimulate VEGF-mediated angiogenesis to alleviate postmenopausal osteoporosis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157259
BibTeX
@article{Cai2025,
author = {Cai, Xiuping and Qiu, Tianxin and Shen, Jiawen and Xu, Yukun and Wu, Zhengting and Lin, Jiehao and Yang, Hongguang and Zhao, Qing and Zhao, Kewei},
title = {Epimedium brevicornu Maxim.-derived extracellular vesicle-like particles stimulate VEGF-mediated angiogenesis to alleviate postmenopausal osteoporosis},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157259}
}
EUVIMED